1. Home
  2. RLAY vs CNS Comparison

RLAY vs CNS Comparison

Compare RLAY & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$18.37

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

HOLD

Current Price

$78.12

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
CNS
Founded
2015
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.7B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
RLAY
CNS
Price
$18.37
$78.12
Analyst Decision
Strong Buy
Hold
Analyst Count
10
2
Target Price
$19.50
$71.50
AVG Volume (30 Days)
4.1M
297.9K
Earning Date
05-05-2026
04-16-2026
Dividend Yield
N/A
3.96%
EPS Growth
31.78
N/A
EPS
N/A
0.82
Revenue
$15,355,000.00
$427,536,000.00
Revenue This Year
N/A
$4.71
Revenue Next Year
$324.03
$4.37
P/E Ratio
N/A
$95.74
Revenue Growth
53.44
4.07
52 Week Low
$3.03
$58.39
52 Week High
$19.93
$79.28

Technical Indicators

Market Signals
Indicator
RLAY
CNS
Relative Strength Index (RSI) 64.92 62.19
Support Level $6.67 $59.88
Resistance Level N/A $78.69
Average True Range (ATR) 1.03 1.97
MACD 0.21 0.02
Stochastic Oscillator 77.66 87.99

Price Performance

Historical Comparison
RLAY
CNS

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two-thirds of its $98.4 billion in managed assets at the end of February. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.

Share on Social Networks: